Immuno-Gene Therapeutics in Hematological Cancers: How Science Drives Study Stra

Presented by

Colin Hayward and Luke Gill

About this talk

This webcast will review the current state of technology in gene therapeutics and examine trends in immuno-oncology and gene therapy for hematological malignancies. Topics will include: - Ingredients for successful study planning and delivery - Operationalizing studies to achieve conclusive data outcomes - Data-driven approach to choosing the right sites in the right countries - Key drivers to retaining patients and meeting study end points - Exploring future trajectories in outsourcing models for innovative biotech companies
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (96)
Subscribers (4594)
Premier Research is a clinical research company, dedicated to helping biotech, specialty pharma, and device innovators transform life-changing ideas and breakthrough science into new medical treatments. As a global company, Premier specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors. Whether it’s developing product lifecycle strategies, reducing clinical development cycle times, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions.